Follow
Shainaba A Saadhali
Shainaba A Saadhali
Other namesShainaba A S
National Institute for Research in Tuberculosis
No verified email
Title
Cited by
Cited by
Year
Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2′-N-acetyltransferase in Mycobacterium tuberculosis
A Prabu, S Hassan, AS Shainaba, LE Hanna, V Kumar
Journal of Molecular Graphics and Modelling 61, 133-140, 2015
472015
Wild-Type MIC distribution for re-evaluating the critical concentration of anti-tb drugs and pharmacodynamics among tuberculosis patients from South India
A Dusthackeer, SA Saadhali, M Thangam, S Hassan, M Balasubramanian, ...
Frontiers in Microbiology 11, 1182, 2020
132020
Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A
SA Saadhali, S Hassan, LE Hanna, UD Ranganathan, V Kumar
Journal of molecular modeling 22, 1-12, 2016
112016
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor
R Mondal, A Dusthackeer VN, P Kannan, AK Singh, K Thiruvengadam, ...
Plos one 18 (3), e0282454, 2023
22023
Nanotheranostic management of drug-resistant tuberculosis
VNA Dustachkeer, CR Nirmal, SE Rajadas, SA Saadhali, S Kannayan, ...
A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy, 149-173, 2021
12021
Discovery of a novel antibiotic, Transitmycin, from Streptomyces sp unveils highly efficient activities against tuberculosis and human immunodeficiency virus
V Kumar, B Ramasamy, M Doble, R Manikkam, LE Hanna, GS Arumugam, ...
medRxiv, 2024.04. 03.24305291, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–6